Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.58 |
| ▸ | LCK | P06239 | 1/20 | 0.58 |
| ▸ | FYN | P06241 | 1/20 | 0.58 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | GABRP | O00591 | 4/20 | 0.43 |
| ▸ | GABRD | O14764 | 4/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.43 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.43 |
| ▸ | GABRG2 | P18507 | 4/20 | 0.43 |
| ▸ | GABRB3 | P28472 | 4/20 | 0.43 |
| ▸ | GABRA5 | P31644 | 4/20 | 0.43 |
| ▸ | GABRA3 | P34903 | 4/20 | 0.43 |
| ▸ | GABRA2 | P47869 | 4/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.43 |
| ▸ | GABRA4 | P48169 | 4/20 | 0.43 |
| ▸ | GABRE | P78334 | 4/20 | 0.43 |
| ▸ | GABRA6 | Q16445 | 4/20 | 0.43 |
| ▸ | GABRG1 | Q8N1C3 | 4/20 | 0.43 |
| ▸ | GABRG3 | Q99928 | 4/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL28157960 | 1.00 | — | — | |
| Acetic Acid SCHEMBL4909758 | 0.96 | FFAR3 (0.54) | FFAR3LCKFYNSLC7A5TP53 | |
| Acetic Acid SCHEMBL11526476 | 0.93 | FFAR3 (0.50) | FFAR3LCKFYNSLC7A5TP53 | |
| Acetic Acid SCHEMBL44094 | 0.92 | — | — | |
| Acetic Acid SCHEMBL27717337 | 0.92 | FFAR3 (0.58) | FFAR3LCKFYNSLC7A5TP53 | |
| Acetic Acid SCHEMBL4292108 | 0.88 | FFAR3 (0.54) | FFAR3LCKFYNSLC7A5TP53 | |
| Acetic Acid SCHEMBL1565106 | 0.88 | — | — | |
| Acetic Acid SCHEMBL8325526 | 0.88 | FFAR3 (0.54) | FFAR3LCKFYNSLC7A5TP53 | |
| Acetic Acid SCHEMBL9720817 | 0.88 | FFAR3 (0.54) | FFAR3LCKFYNSLC7A5TP53 | |
| Acetic Acid SCHEMBL6051117 | 0.88 | FFAR3 (0.54) | FFAR3LCKFYNSLC7A5TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11497206-B2 | Cell cryopreservation protective composition and use thereof | TIANJIN UNIVERSITY (CN) | 2022-11-15 | — | — | US | claimed |
| CN-115093274-A | Preparation method of liquid fertilizer chelating agent | 达塔进出口有限公司 | 2022-09-23 | — | — | CN | claimed |
| CN-110412106-B | Method for performing oil source comparison by using molybdenum isotope | 中国石油天然气股份有限公司 | 2022-03-29 | — | — | CN | claimed |
| CN-109554376-B | Alkaline urate oxidase and application thereof in detection kit and reduction of uric acid in food | 广西大学 | 2022-03-22 | — | — | CN | claimed |
| US-11234925-B2 | Stable aqueous injectable solution of epinephrine | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2022-02-01 | — | — | US | claimed |
| US-20190037832-A1 | Cell Cryopreservation Protective Composition, Use Thereof, and Cell Cryopreservation Method | TIANJIN UNIVERSITY (CN) | 2019-02-07 | — | — | US | claimed |
| EP-2021793-A1 | POLYMER BACKBONE ELEMENT TAGS | Winnik, Mitchell A. (CA) | 2009-02-11 | — | — | EP | claimed |
| WO-2007137418-A1 | POLYMER BACKBONE ELEMENT TAGS | WINNIK MITCHELL A (CA) | 2007-12-06 | — | — | WO | claimed |
| US-20240409612-A1 | IMPROVED PURIFICATION PROCESS | CSL BEHRING AG (CH) | 2024-12-12 | — | — | US | disclosed |
| EP-4408562-A1 | IMPROVED PURIFICATION PROCESS | CSL Behring AG (CH) | 2024-08-07 | — | — | EP | disclosed |
| CN-113453663-B | Stable injectable aqueous epinephrine solutions | 太阳医药工业有限公司 | 2024-07-05 | — | — | CN | disclosed |
| WO-2023143345-A1 | TOFACITINIB-CONTAINING PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION, PREPARATION, AND USE THEREOF | 杭州和正医药有限公司 | 2023-08-03 | — | — | WO | disclosed |
| CN-116492293-A | Tofacitinib-containing pharmaceutical composition for local application, preparation and application | 杭州和正医药有限公司 | 2023-07-28 | — | — | CN | disclosed |
| CN-113975280-B | Pharmaceutical composition containing tofacitinib pharmaceutically acceptable salt, preparation and application | 杭州和正医药有限公司 | 2023-05-16 | — | — | CN | disclosed |
| EP-0772682-B1 | MODIFICATION OF STARCH CONTENT IN PLANTS | CAMBRIDGE ADVANCED TECH (GB) | 2005-09-21 | — | — | EP | disclosed |
| US-6486383-B1 | Modification of starch content in plants | ADVANCED TECHNOLOGIES (CAMBRIDGE) LIMITED (GB) | 2002-11-26 | — | — | US | disclosed |
| US-6096945-A | AMPLIFICATION OF PHOSPHORYLASE ACTIVITY IN MAIZE, WHEAT, RICE, POTATO, PEAS, PEANUT, CASSAVA, BEANS, CARROTS, TOMATO AND TOBACCO; INSERTION OF GENE CODING A PEPTIDE CHAIN OF PHOSPHORYLASE, SCREEN FOR AMPLIFIED GENE EXPRESSION IN PLANTS | ADVANCED TECHNOLOGIES (CAMBRIDGE) LIMITED (GB) | 2000-08-01 | — | — | US | disclosed |
| EP-0772682-A1 | MODIFICATION OF STARCH CONTENT IN PLANTS | ADVANCED TECHNOLOGIES (CAMBRIDGE) LIMITED (GB) | 1997-05-14 | — | — | EP | disclosed |
| WO-1995034660-A1 | MODIFICATION OF STARCH CONTENT IN PLANTS | ADVANCED TECHNOLOGIES (CAMBRIDGE) LIMITED (GB) | 1995-12-21 | — | — | WO | disclosed |
| US-3713982-A | ENZYME CHEMICALLY COUPLED TO CELLULOSE ETHER | RANKS HOVIS MCDOUGALL LTD | 1973-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190037832-A1 | Cell Cryopreservation Protective Composition, Use Thereof, and Cell Cryopreservation Method | BCL2, BAX, BCL2A1 | FFAR3 498/4885LCK 3548/4885FYN 3227/4885 |
| US-11497206-B2 | Cell cryopreservation protective composition and use thereof | BCL2, BAX, BCL2A1 | FFAR3 580/4885LCK 3503/4885FYN 3437/4885 |
| US-11234925-B2 | Stable aqueous injectable solution of epinephrine | ALB, SELE, S100A11 | FFAR3 860/4885LCK 2109/4885FYN 1972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.